Inside RFK Jr.’s financials: Biotech, health care, ‘introductions’

Inside RFK Jr.’s financials: Biotech, health care, 'introductions'

Prospective health secretary Robert F. Kennedy Jr. invested in biotechnology and had multiple sources of income in 2022 and 2023, financial disclosures show. 

The documents, which STAT obtained through a public records request, offer more insight into Kennedy’s finances as he meets with lawmakers in Washington in hopes of securing his Senate confirmation. As head of the Department of Health and Human Services, Kennedy would need to follow a code of ethics that advises employees to avoid financial conflicts of interest — an issue he has made central to his “Make America Healthy Again” pitch. He would need to stop practicing law, unless it is unpaid work as a community service, or the deputy attorney general gives Kennedy permission to continue. 

Last year, tax filings showed Kennedy made over $20,000 per week as chairman and chief legal counsel of his nonprofit, Children’s Health Defense, before stepping away to run for president. The new documents confirm Kennedy took a leave of absence from his roles at the nonprofit on April 1, 2023, and stopped receiving pay and benefits. 

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

By admin

Leave a Reply

Your email address will not be published. Required fields are marked *